Novartis AG

A Survival Analysis Approach to Predicting Severe Leukopenia in Advanced Breast Cancer Patients (2024) Vodenčarević A, Kreuzeder J, Wöckel A, Fasching P Conference contribution Fiber alignment in 3D collagen networks as a biophysical marker for cell contractility (2023) Böhringer D, Bauer A, Moravec I, Bischof L, Kah DTE, Mark C, Grundy TJ, et al. Journal article Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension (2023) D'Agostino MA, Carron P, Gaillez C, Conaghan PG, Naredo E, López-Rdz A, Šenolt L, et al. Journal article Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant (2023) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Journal article Assessing real-world gait with digital technology? Validation, insights and recommendations from the Mobilise-D consortium (2023) Micó-Amigo ME, Bonci T, Paraschiv-Ionescu A, Ullrich M, Kirk C, Soltani A, Küderle A, et al. Journal article Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2- Advanced Breast Cancer: Findings From a Multicountry Survey (2023) Cardoso F, Rihani J, Harmer V, Harbeck N, Casas A, Rugo HS, Fasching P, et al. Journal article Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis (2023) Fitzgerald O, Behrens F, Barton A, Bertheusen H, Boutouyrie-Dumont B, Coates L, Davies O, et al. Journal article, Review article COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma (2023) Berking C, Livingstone E, Debus D, Loquai C, Weichenthal M, Leiter U, Kiecker F, et al. Journal article Laboratory and free-living gait performance in adults with COPD and healthy controls (2023) Buekers J, Megaritis D, Koch S, Alcock L, Ammour N, Becker C, Bertuletti S, et al. Journal article Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial (2023) Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, et al. Journal article